Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 23 Artikel )

25.06.2019 | Review Article | Ausgabe 2/2019

Cancer immunotherapy: the art of targeting the tumor immune microenvironment

Jesse Lopes da Silva, Alexssandra Lima S. Dos Santos, Natalia Cristina Cardoso Nunes, Flora de Moraes Lino da Silva, Carlos Gil Moreira Ferreira, Andreia Cristina de Melo

22.05.2019 | Review Article | Ausgabe 2/2019

The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment

Vasiliki Galani, Anna Varouktsi, Stamatis S. Papadatos, Antigoni Mitselou, Ioannis Sainis, Stavros Constantopoulos, Yotanna Dalavanga

27.05.2019 | Review Article | Ausgabe 2/2019 Open Access

Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations

Carmen F. Nobre, Matthew J. Newman, Anne DeLisa, Pauline Newman

21.05.2019 | Original Article | Ausgabe 2/2019

Priming with GM-CSF instead of G-CSF enhances CAG-induced apoptosis of acute monocytic leukemia cells in vitro

Meiqing Lei, Limin Liu, Depei Wu

14.06.2019 | Original Article | Ausgabe 2/2019

Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients

Kazutaka Hosoya, Daichi Fujimoto, Hayato Kawachi, Yuki Sato, Mariko Kogo, Kazuma Nagata, Atsushi Nakagawa, Ryo Tachikawa, Shinya Hiraoka, Masaki Kokubo, Keisuke Tomii

12.04.2019 | Original Article | Ausgabe 2/2019

Neoadjuvant chemotherapy in patients with advanced endometrial cancer

Olivia R. Khouri, Melissa K. Frey, Fernanda Musa, Franco Muggia, Jessica Lee, Leslie Boyd, John P. Curtin, Bhavana Pothuri

22.04.2019 | Original Article | Ausgabe 2/2019

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

Deysi Viviana Tenazoa Wong, Helder Veras Ribeiro-Filho, Carlos Wagner Souza Wanderley, Caio Abner Vitorino Gonçalves Leite, Jonilson Berlink Lima, Alexia Nathália Brígido Assef, Aurilene Gomes Cajado, Gabriela Loiola Ponte Batista, Rafael Holanda González, Karla Oliveira Silva, Luis Philipi Carvalho Borges, Nylane Maria Nunes Alencar, Diego Veras Wilke, Thiago Mattar Cunha, Ana Carolina Migliorini Figueira, Fernando Queiroz Cunha, Roberto César Pereira Lima-Júnior

29.04.2019 | Original Article | Ausgabe 2/2019

Postoperative chemotherapy as adjuvant treatment for endometrioid adenocarcinoma: early stage vs late stage

Mengmeng Lu, Jiaojiao Zheng, Nana Xu, Han Lin, Shaogui Wan

07.05.2019 | Original Article | Ausgabe 2/2019

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer

Takeshi Suzuki, Eiji Shinozaki, Hiroki Osumi, Izuma Nakayama, Yumiko Ota, Takashi Ichimura, Mariko Ogura, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin, Kensei Yamaguchi

14.05.2019 | Original Article | Ausgabe 2/2019

A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer

Guoying Jin, Yuhang Liu, Jia Zhang, Zehua Bian, Surui Yao, Bojian Fei, Leyuan Zhou, Yuan Yin, Zhaohui Huang

01.06.2019 | Original Article | Ausgabe 2/2019

Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII

Mark Rosenthal, Richard Curry, David A. Reardon, Erik Rasmussen, Vijay V. Upreti, Michael A. Damore, Haby A. Henary, John S. Hill, Timothy Cloughesy

12.06.2019 | Original Article | Ausgabe 2/2019

Phase I study of BGT226, a pan-PI3K and mTOR inhibitor, in Japanese patients with advanced solid cancers

Hironobu Minami, Yutaka Fujiwara, Kei Muro, Masahiko Sato, Atsuko Moriya

26.06.2019 | Original Article | Ausgabe 2/2019

Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells

Satoru Matsunuma, Satoko Handa, Daisuke Kamei, Hitomi Yamamoto, Kiyoshi Okuyama, Yasuhisa Kato

16.04.2019 | Original Article | Ausgabe 2/2019 Open Access

A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer

Yasuhiro Kato, Yusuke Okuma, Kageaki Watanabe, Makiko Yomota, Shoko Kawai, Yukio Hosomi, Tatsuru Okamura

17.05.2019 | Original Article | Ausgabe 2/2019

Exposure time versus cytotoxicity for anticancer agents

David M. Evans, Jianwen Fang, Thomas Silvers, Rene Delosh, Julie Laudeman, Chad Ogle, Russell Reinhart, Michael Selby, Lori Bowles, John Connelly, Erik Harris, Julia Krushkal, Larry Rubinstein, James H. Doroshow, Beverly A. Teicher

27.05.2019 | Original Article | Ausgabe 2/2019 Open Access

Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis

Aurélie Pétain, Dafang Zhong, Xiaoyan Chen, Zhang Li, Shao Zhimin, Jiang Zefei, Grégoire Zorza, Pierre Ferré

11.06.2019 | Original Article | Ausgabe 2/2019

The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors

Shodeinde A. Coker, Herbert I. Hurwitz, Sunil Sharma, Ding Wang, Pierre Jordaan, Juan Pablo Zarate, Lionel D. Lewis

21.06.2019 | Original Article | Ausgabe 2/2019 Open Access

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors

Toshihiko Doi, Yutaka Fujiwara, Nobuaki Matsubara, Junichi Tomomatsu, Satoru Iwasa, Akari Tanaka, Chihiro Endo-Tsukude, Shintaro Nakagawa, Shunji Takahashi

27.06.2019 | Original Article | Ausgabe 2/2019

Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors

Gyuri Kim, Myungeun Yoo, Min Hee Hong, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hye Ryun Kim, Yong-ho Lee, Byoung Chul Cho

27.06.2019 | Original Article | Ausgabe 2/2019

MSI2-TGF-β/TGF-β R1/SMAD3 positive feedback regulation in glioblastoma

Xingjun Jiang, Jun Tan, Yin Wen, Weidong Liu, Shuyu Wu, Lei Wang, Siyi Wangou, Dingyang Liu, Can Du, Bin Zhu, Dan Xie, Caiping Ren

13.05.2019 | Original Article | Ausgabe 2/2019

MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer

Ping Zhao, Yu-guang Ma, Yang Zhao, Di Liu, Zhi-jun Dai, Chang-you Yan, Hai-tao Guan

04.04.2019 | Short Communication | Ausgabe 2/2019

An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine

I. Kümler, R. L. Eefsen, Peter Grundtvig Sørensen, S. Theile, A. Fullerton, P. G. Nielsen, Benny Vittrup Jensen, D. L. Nielsen

11.05.2019 | Short Communication | Ausgabe 2/2019

CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors

Yogesh T. Patel, Abigail Davis, Suzanne J. Baker, Olivia Campagne, Clinton F. Stewart

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise